MARZOLA, Erika
 Distribuzione geografica
Continente #
NA - Nord America 3.257
EU - Europa 1.008
AS - Asia 601
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.888
Nazione #
US - Stati Uniti d'America 3.242
IT - Italia 292
CN - Cina 244
SG - Singapore 199
UA - Ucraina 150
PL - Polonia 133
DE - Germania 127
GB - Regno Unito 107
TR - Turchia 98
FI - Finlandia 69
SE - Svezia 50
ID - Indonesia 31
BE - Belgio 27
FR - Francia 16
CA - Canada 15
LT - Lituania 10
IR - Iran 9
CO - Colombia 8
NL - Olanda 8
IN - India 7
BR - Brasile 6
CZ - Repubblica Ceca 5
IE - Irlanda 5
VN - Vietnam 5
PE - Perù 4
RU - Federazione Russa 4
A2 - ???statistics.table.value.countryCode.A2??? 2
HK - Hong Kong 2
IL - Israele 2
PT - Portogallo 2
AR - Argentina 1
AT - Austria 1
CL - Cile 1
HU - Ungheria 1
JP - Giappone 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
TH - Thailandia 1
Totale 4.888
Città #
Fairfield 423
Woodbridge 404
Ann Arbor 238
Ashburn 213
Houston 212
Seattle 181
Santa Clara 180
Singapore 172
Jacksonville 168
Chandler 166
Ferrara 150
Cambridge 149
Wilmington 147
Warsaw 132
New York 62
Izmir 59
Milan 53
Princeton 52
Dearborn 47
Nanjing 46
Addison 44
Beijing 44
Helsinki 39
Shanghai 39
San Diego 36
Jakarta 31
Boardman 30
Brussels 25
Los Angeles 18
Auburn Hills 16
Munich 16
Redwood City 16
London 15
Nanchang 14
Bremen 12
San Mateo 12
Ferrara di Monte Baldo 11
Shenyang 11
Changsha 10
Hebei 10
Mountain View 10
Jinan 8
Toronto 8
Jiaxing 7
Medellín 7
Ningbo 7
Norwalk 7
Philadelphia 7
Tappahannock 7
Turin 7
Washington 7
Augusta 6
Falkenstein 6
Frankfurt am Main 6
Zhengzhou 6
Bologna 5
Dong Ket 5
Dublin 5
Falls Church 5
Kunming 5
Istanbul 4
Jena 4
Leawood 4
Lima 4
Padova 4
Parma 4
Tianjin 4
Des Moines 3
Grassano 3
Indiana 3
Lanzhou 3
Olomouc 3
Ottawa 3
Prescot 3
Taizhou 3
Brno 2
Catania 2
Charlottesville 2
Chiswick 2
Guangzhou 2
Haikou 2
Hohenhameln 2
Hong Kong 2
Imola 2
Jerusalem 2
Manchester 2
Monmouth Junction 2
Montechiarugolo 2
Napoli 2
Occhiobello 2
Oderzo 2
Orange 2
Porto 2
Rome 2
San Francisco 2
Torino 2
Utrecht 2
Wuhan 2
Amsterdam 1
Anyang 1
Totale 3.934
Nome #
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 185
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 180
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 171
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 150
Physicochemical stability of cabazitaxel and docetaxel solutions 150
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 148
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 147
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 147
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 144
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 143
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 140
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 134
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 131
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 125
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 125
Pharmacological characterization of tachykinin tetrabranched derivatives 121
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 120
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 120
Structure-activity study at positions 3 and 4 of human neuropeptide S. 118
Synthesis and antimicrobial activity of dermaseptin S1 analogues 114
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 113
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 112
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 110
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 109
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 105
Structure-activity relationship study on human urotensin II 104
Thermodynamic and spectroscopic investigation on the role of Met residues in CuII binding to the non-octarepeat site of the human Prion protein 102
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 102
Role of 2′,6′-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds 101
null 94
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 91
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 91
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 91
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 84
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 81
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 77
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 58
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 51
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 50
Novel Mixed NOP/Opioid Receptor Peptide Agonists 49
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 47
null 42
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 40
The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues 40
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 40
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 34
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 34
CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis 30
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 26
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 24
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 23
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity 18
Positively charged residues play a significant role in enhancing the antibacterial activity of calcitermin 9
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 7
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 7
Totale 5.009
Categoria #
all - tutte 25.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 305
Totale 25.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020570 0 0 0 0 0 129 115 104 86 67 40 29
2020/2021729 42 53 43 82 37 67 79 83 36 71 95 41
2021/2022595 28 53 47 42 33 14 35 37 37 51 55 163
2022/2023485 58 31 26 54 62 50 55 50 46 2 29 22
2023/2024396 31 41 26 10 16 90 17 46 10 11 18 80
2024/2025587 35 29 146 62 175 140 0 0 0 0 0 0
Totale 5.009